Role of Inflammation in Diabetic Retinopathy
Open accessThe DOI matches its Crossref record; 248 of the 249 references it cites were found in a registry or an index.
Abstract
Diabetic retinopathy is a common complication of diabetes and remains the leading cause of blindness among the working-age population. For decades, diabetic retinopathy was considered only a microvascular complication, but the retinal microvasculature is intimately associated with and governed by neurons and glia, which are affected even prior to clinically detectable vascular lesions. While progress has been made to improve the vascular alterations, there is still no treatment to counteract the early neuro-glial perturbations in diabetic retinopathy. Diabetes is a complex metabolic disorder, characterized by chronic hyperglycemia along with dyslipidemia, hypoinsulinemia and hypertension. Increasing evidence points to inflammation as one key player in diabetes-associated retinal perturbations, however, the exact underlying molecular mechanisms are not yet fully understood. Interlinked molecular pathways, such as oxidative stress, formation of advanced glycation end-products and increased expression of vascular endothelial growth factor have received a lot of attention as they all contribute to the inflammatory response. In the current review, we focus on the involvement of inflammation in the pathophysiology of diabetic retinopathy with special emphasis on the functional relationships between glial cells and neurons. Finally, we summarize recent advances using novel targets to inhibit inflammation in diabetic retinopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and this might explain the difference in rates of intraocular inflammation between eyes with diabetic retinopathy and those with AMD, despite being treated with the same vector and concentration.”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [82]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Inflammatory processes are known to be integral in the pathogenesis of diabetic retinopathy,82”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rajamani, U., & Jialal, I. (2014) · Journal of Diabetes Research · doi:10.1155/2014/790902 · Cited by 114
RetractedInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Wh n ot resolved in a timely fashion the typically b nefici l eff ct of inflammation is lost a d dramatic consequence ensues [43].”
Background(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Toll-Like Receptor Signaling Pathways
Kawasaki, T., & Kawai, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00461 · Cited by 3,233
Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961
Matrix metalloproteinases as modulators of inflammation and innate immunity
Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929
Reactive astrocytes: cellular and molecular cues to biological function
Ridet, J. L., Privat, A., Malhotra, S. K., & Gage, F. H. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01139-9 · Cited by 1,766
Müller cells in the healthy and diseased retina
BRINGMANN, A., PANNICKE, T., GROSCHE, J., FRANCKE, M., WIEDEMANN, P., SKATCHKOV, S., OSBORNE, N., & REICHENBACH, A. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.05.003 · Cited by 1,711
Antonetti, D. A., Klein, R., & Gardner, T. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1005073 · Cited by 1,659
Research works printed but not linked: 1
- (2017, October 30). Allegro Ophthalmics Announces Positive Topline Results from Del Mar Phase 2b Trial Evaluating Luminate® in Patients with Diabetic Macular Edema. Available online: http://www.allegroeye.com/press.
Cited by
Items 101–200 of 749
Measurable Aspects of the Retinal Neurovascular Unit in Diabetes, Glaucoma, and Controls
Spaide, R. F. (2019) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2019.04.035 · Cited by 68
Diabetic Retinopathy in Patients With Diabetic Foot Ulcer: A Systematic Review
Şerban, D., Παπάνας, Ν., Dascălu, A. M., Stana, D., Nicolae, V. A., VANCEA, G., Badiu, C. D., Tănăsescu, D., Tudor, C., Balasescu, S., et al. (2020) · The International Journal of Lower Extremity Wounds · doi:10.1177/1534734620982237 · Cited by 55
Retinal inflammation in murine models of type 1 and type 2 diabetes with diabetic retinopathy
Dharmarajan, S., Carrillo, C., Qi, Z., Wilson, J. M., Baucum, A. J., Sorenson, C. M., Sheibani, N., & Belecky‐Adams, T. L. (2023) · Diabetologia · doi:10.1007/s00125-023-05995-4 · Cited by 54
“While various inflammatory factors have been studied for their effects on the retinal vasculature, most of these studies were focused on later, more severe, stages in models of type 1 and type 2 diabetes [11].”
BackgroundSheng, X., Zhang, C., Zhao, J., Xu, J., Zhang, P., Ding, Q., & Zhang, J. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01269-7 · Cited by 59
“Hyperglycemia increased astrocytes to produce many inflammatory cytokines such as interleukin (IL)-1β and IL-6 to amplify the inflammation in retina [148].”
BackgroundEGFL7 regulates sprouting angiogenesis and endothelial integrity in a human blood vessel model
Usuba, R., Pauty, J., Soncin, F., & Matsunaga, Y. T. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.01.022 · Cited by 50
Liu, H., Stepicheva, N. A., Ghosh, S., Shang, P., Chowdhury, O., Daley, R. A., Yazdankhah, M., Gupta, U., Hose, S., Valapala, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33773-0 · Cited by 46
Self-citationLiu, F., SAUL, A. B., Pichavaram, P., Xu, Z., Rudraraju, M., Somanath, P. R., Smith, S. B., Caldwell, R. B., & Narayanan, S. P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020340 · Cited by 43
Cell and molecular targeted therapies for diabetic retinopathy
Reddy, S. K., Devi, V., Seetharaman, A. T. M., Shailaja, S., Bhat, K. M. R., Gangaraju, R., & Upadhya, D. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1416668 · Cited by 52
Martins, B. D., Amorim, M., Reis, F., Ambrósio, A. F., & Fernandes, R. (2020) · Antioxidants · doi:10.3390/antiox9080705 · Cited by 48
“Nevertheless, this whole scenario is dynamic at different stages of the natural history of DR and varies from individual to individual [24,26].”
BackgroundPPARα Agonist Oral Therapy in Diabetic Retinopathy
Tomita, Y., Lee, D., Tsubota, K., & Kurihara, T. (2020) · Biomedicines · doi:10.3390/biomedicines8100433 · Cited by 47
“Even though the pathogenesis of DR remains unclear, evidence suggests that DR at least contains chronic inflammation [69,70] and the microglia can be considered one of the principle cells sensing the stimuli in diabetic conditions and releasing pro-inflammatory and neurotoxic cytokines [67].”
BackgroundInflammation and diabetic retinopathy.
Uçgun, N. İ., Fikret, C. Z., & Yıldırım, Z. (2020) · PubMed Central · Cited by 42
Daidzein ameliorates diabetic retinopathy in experimental animals
Laddha, A. P., & Kulkarni, Y. A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118779 · Cited by 42
Neurovascular Impairment and Therapeutic Strategies in Diabetic Retinopathy
Oshitari, T. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19010439 · Cited by 45
Diabetic complications and prospective immunotherapy
Reynolds, L., Luo, Z., & Singh, K. N. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1219598 · Cited by 51
“The presence of neovascularization and edema in DR provides evidence of a defining hallmark of inflammation (21, 29, 30).”
BackgroundAssociation of the Monocyte–to–High-Density Lipoprotein Cholesterol Ratio With Diabetic Retinopathy
Tang, X., Tan, Y. C. R. S., Yang, Y., Li, M., He, X., Lü, Y., Shi, G., Zhu, Y., Nie, Y., Li, H., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.707008 · Cited by 45
“evidence indicates that inflammation plays a key role in the pathophysiology of DR (7).”
BackgroundNuclear factor of activated T-cells (NFAT) regulation of IL-1β-induced retinal vascular inflammation
Giblin, M. J., Smith, T. E., Winkler, G. A., Pendergrass, H. A., Kim, M. J., Capozzi, M. E., Yang, R., McCollum, G. W., & Penn, J. S. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166238 · Cited by 42
Li, Z., Yuan, Y., Qi, Q., Wang, Q., & Li, F. (2023) · Systematic Reviews · doi:10.1186/s13643-023-02321-2 · Cited by 56
“Diabetic retinopathy (DR), one of the chronic micro-vascular complications of diabetes [4], affects more than 80% of patients with diabetes for whom the disease course exceeds 20 years and in some cases can lead to irreversible visual loss [5].”
BackgroundZhou, J., Zhu, L., & Li, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1302127 · Cited by 50
Hu, G., Gu, L., Wang, R., Jian, Q., Lv, K., Xia, M., Lai, M., Shen, T., Hu, J., Yang, S., et al. (2024) · 中国科学通报:英文版 · doi:10.1016/j.scib.2023.12.053 · Cited by 41
Targeting Neurovascular Interaction in Retinal Disorders
Fu, Z., Sun, Y., Cakir, B., Tomita, Y., Huang, S., Wang, Z., Liu, C., Cho, S. S., Britton, W. R., Kern, T. S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041503 · Cited by 50
Role of Oral Antioxidant Supplementation in the Current Management of Diabetic Retinopathy
Alfonso-Muñoz, E. A., Matas, R. B.-S. D. L., Mataix, J., Martín, J. C. M., & Desco, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084020 · Cited by 53
“Under inflammatory stimuli, endothelial cells increase the expression of intracellular and vascular adhesion molecules (ICAM-1 and VCAM-1) and E-selectin, allowing leukocyte adhesion to the endothelial cell walls and the production of leukostasis, which is a determining factor for posterior microvascular damage [26,27…”
BackgroundSelf-assembling tacrolimus nanomicelles for retinal drug delivery
Gote, V., Mandal, A., Alshamrani, M., & Pal, D. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111072 · Cited by 39
“This further aggravates inflammation [13].”
Ramos, H., Hernández, C., Simó, R., & Simó‐Servat, O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108796 · Cited by 47
“This inflammatory component of the disease is intimately associated with all the hallmarks of DR, contributing to the neurodegenerative process and the vascular abnormalities of the diabetic retina [18].”
BackgroundZhou, Z., Chang, T., Lin, Z., Jing, Y., Wen, L.-S., Niu, Y., Bai, Q., Guo, C., Sun, J., Wang, Y., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05897-8 · Cited by 42
de Gaetano, M., McEvoy, C. M., Andrews, D. C., Cacace, A., Hunter, J., Brennan, E. P., & Godson, C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01488 · Cited by 44
Gene polymorphism and plasma levels of miR-155 in diabetic retinopathy
Polina, E. R., de Oliveira, F. M., Sbruzzi, R. C., Crispim, D., Canani, L. H. S., & dos Santos, K. G. (2019) · Endocrine Connections · doi:10.1530/ec-19-0446 · Cited by 42
de Viteri, M. S., Hernández, M., Bilbao‐Malavé, V., Fernández‐Robredo, P., González‐Zamora, J., García‐García, L., Ispízua, N., Recalde, S., & García‐Layana, A. (2020) · Antioxidants · doi:10.3390/antiox9090828 · Cited by 48
“These include the polyol pathway [3], non-enzymatic glycation [4], activation of protein kinase C (PKC) [5], oxidative stress [6–10], and inflammation through proinflammatory cytokines, chemokines, and other inflammatory mediators [11,12].”
BackgroundChen, Y., Yao, G., Tong, J., Xie, H., Zheng, X., Zhang, H., & Xie, Z. (2023) · Stem Cells · doi:10.1093/stmcls/sxad078 · Cited by 41
Tumor necrosis factor-α and diabetic retinopathy: Review and meta-analysis
Yao, Y., Li, R., Du, J., Li, X., Zhao, L. Q., Long, L., Li, D., & Lu, S. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.06.028 · Cited by 38
Wang, W., Tam, K. C., Ng, T. C., Goit, R. K., Chan, K. L.-S., & Lo, A. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001519 · Cited by 46
Recent Insights into the Etiopathogenesis of Diabetic Retinopathy and Its Management
Biswas, A., Choudhury, A. D., Agrawal, S., Bisen, A. C., Sanap, S. N., Verma, S. K., Kumar, M., Mishra, A., Kumar, S., Chauhan, M., et al. (2023) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2023.0068 · Cited by 43
Li, Y., Gappy, S. S., Liu, X., Sassalos, T. M., Zhou, T., Hsu, A., Zhang, A., Edwards, P. A., Gao, H., & Qiao, X. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268451 · Cited by 43
“Numerous clinical and experimental research have suggested that chronic inflammation plays a critical role in the early stages of DR, when capillary damage, retinal ischemia, and vascular hyperpermeability occur [3, 4].”
BackgroundDNA methylation in diabetic retinopathy: pathogenetic role and potential therapeutic targets
Cai, C., Meng, C., He, S., Gu, C., Lhamo, T., Draga, D., Luo, D., & Qiu, Q. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00927-y · Cited by 45
“Studies have found various inflammation-related phenomena in the retina of DR patients, including leukostasis, neutrophil and macrophage infiltration, complement and microglial activation, and increased vascular permeability [61].”
BackgroundXie, J., Cui, Y., Chen, X., Yu, H., Chen, J., Huang, T., He, M., Zhang, L., & Meng, Q. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108640 · Cited by 37
Retinal fundus image classification for diabetic retinopathy using SVM predictions
Hardas, M., Mathur, S., Bhaskar, A., & Kalla, M. (2022) · Physical and Engineering Sciences in Medicine · doi:10.1007/s13246-022-01143-1 · Cited by 41
Retinal fundus image classification for diabetic retinopathy using transfer learning technique
Kallel, F., & Echtioui, A. (2023) · Signal Image and Video Processing · doi:10.1007/s11760-023-02820-8 · Cited by 35
Subauste, C. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02958 · Cited by 38
Jiang, L., Wang, C., & Shen, X.-Y. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11163 · Cited by 35
Portillo, J. C., Yu, J., Vos, S., Bapputty, R., Corcino, Y. L., Hubal, A., Daw, J., Arora, S., Sun, W., Lu, Z., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05775-6 · Cited by 37
He, X., Qi, S., Zhang, X., & Pan, J. (2022) · BMC Ophthalmology · doi:10.1186/s12886-022-02571-z · Cited by 40
“Several studies found that inflammation had an essential role in different stages of DR [31, 32].”
BackgroundEynard, A. R., & Repossi, G. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1049-9 · Cited by 40
Takayanagi, Y., Yamanaka, M., Fujihara, J., Matsuoka, Y., Gohto, Y., Obana, A., & Tanito, M. (2020) · Antioxidants · doi:10.3390/antiox9111100 · Cited by 36
“In addition, a number of studies have revealed that inflammation is a critical contributor for the development of PDR [33], and AGEs can initiate inflammatory process via RAGE-mediated NF-κB signaling pathways [34].”
BackgroundSheemar, A., Soni, D., Takkar, B., Basu, S., & Venkatesh, P. (2021) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_1326_21 · Cited by 40
“The Müller cells are the main source of increased vascular endothelial growth factor (VEGF) expression in the diabetic retina along with a significant contribution from the endothelial cells, astrocytes, and retinal pigment epithelial cells (RPEs).[19] Hyperglycemia, increased oxidative stress, hypoxia, and the synerg…”
BackgroundDascălu, A. M., Şerban, D., Tănăsescu, D., VANCEA, G., Cristea, B. M., Stana, D., Nicolae, V. A., Serboiu, C. S., Tribus, L. C., Tudor, C., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11082106 · Cited by 44
“Chronic hyperglycemia induces both neurodegeneration and apoptosis of the retinal ganglion cells and photoreceptors and causes microvascular retinal damages by multiple pathways: activation of aldose-reductase and polyol pathway, activation of the protein kinase C (PKC) pathway, accumulation of reactive oxygen species…”
BackgroundRAGE plays key role in diabetic retinopathy: a review
Lu, Z., Fan, B., Li, Y., & Zhang, Y. (2023) · BioMedical Engineering OnLine · doi:10.1186/s12938-023-01194-9 · Cited by 38
“Therapeutic agents that exhibit anti-inflammatory and/or anti-angiogenic activity have been widely used to slow the progression of DR and treat complications, such as intravitreal injection of anti-VEGF inhibitors and steroids [9].”
BackgroundMethodInfluentialPI3Kδ as a Novel Therapeutic Target in Pathological Angiogenesis
Wu, W., Zhou, G., Han, H., Huang, X., Jiang, H., Mukai, S., Kazlauskas, A., Cui, J. Z., Matsubara, J. A., Vanhaesebroeck, B., et al. (2020) · Diabetes · doi:10.2337/db19-0713 · Cited by 33
“As TNF-a induces p110d expression in ECs (22) and inflammation plays an important role in diabetic retinopathy (40,41), we examined whether p110d was expressed in ECs in FVMs from patients with PDR.”
BackgroundMansour, S. E., Kiernan, D. F., Roth, D. B., Eichenbaum, D. A., Holekamp, N. M., Kaba, S. E., & Werts, E. (2020) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2020-315984 · Cited by 33
High glucose induces pyroptosis of retinal microglia through NLPR3 inflammasome signaling
Huang, L., You, J., Yao, Y., & Xie, M. (2021) · Arquivos Brasileiros de Oftalmologia · doi:10.5935/0004-2749.20210010 · Cited by 42
“Although DR has been traditionally described as a microvascular disorder, recent evidence demonstrated that early DR is linked to retinal inflammation associated with microglia activation(4-5).”
BackgroundYan, M., Wang, H., Gu, Y., Li, X., Tao, L., & Lu, P. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108521 · Cited by 33
Santos, F. M., Ciordia, S., Mesquita, J., Sousa, J. P. C., Paradela, A., Tomaz, C. T., & Passarinha, L. A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04670-y · Cited by 43
“Hyperglycemia-induced pathways [36, 220], hypoxic–ischemic conditions [221], and the activation of retinal glial cells, macrophages, and retinal neurons [222, 223] promote a pro-inflammatory environment that may disrupt the delicate balance of BRB.”
BackgroundChen, C., Ding, P., Yan, W., Wang, Z., Lan, Y., Yan, X., Li, T. X., & Han, J. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115643 · Cited by 34
Wu, J., Duan, C., Yang, Y., Wang, Z., Tan, C., Han, C., & Hou, X. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04543-3 · Cited by 33
“Recently, it has also been found that high levels of blood glucose could cause injuries directly on neuronal cells (neuroretina), even prior to the breakdown of the blood-retinal barrier (BRB), to promote neurodegeneration, neuronal cell death, and eventually DR [74].”
BackgroundNeutrophil Extracellular Traps: Current Perspectives in the Eye
Estúa-Acosta, G. A., Zamora-Ortiz, R., Buentello‐Volante, B., García-Mejía, M., & Garfias, Y. (2019) · Cells · doi:10.3390/cells8090979 · Cited by 38
Hernández, C., Arroba, A. I., Bogdanov, P. M., Ramos, H., Simó‐Servat, O., Simó, R., & Valverde, Á. M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082579 · Cited by 34
“These inflammatory mediators pay an essential role in early neuronal cell death that occurs in the diabetic retina [30].”
BackgroundYang, Y., Zhou, M., & Liu, H. (2021) · Physiology International · doi:10.1556/2060.2021.00148 · Cited by 32
“The literature suggests that the inflammation involved in the development of DR, and retinal tissue necrosis and apoptosis is caused by elevated caspase-1 expression [8].”
BackgroundRalston, K., Newman, C., Clauson, A. L., Guthrie, J. F., & Buzby, J. C. (2008) · Cited by 100
Antioxidant Effects of DPP-4 Inhibitors in Early Stages of Experimental Diabetic Retinopathy
Ramos, H., Bogdanov, P. M., Huerta, J., Deàs-Just, A., Hernández, C., & Simó, R. (2022) · Antioxidants · doi:10.3390/antiox11071418 · Cited by 34
“Hyperglycemia-induced oxidative stress leads to other pathological events, such as inflammation [36].”
BackgroundLee, S., Lee, E. J., Lee, G. M., Yun, J.-H., & Yoo, W. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1162934 · Cited by 33
“Thus, inflammatory dysfunction of RPE cells can lead to various pathological conditions including age-related macular degeneration (AMD), proliferative vitreoretinopathy (PVR), and diabetic retinopathy (DR) (1, 3).”
BackgroundWang, Y., Eshwaran, R., Beck, S. C., Hammes, H., Wieland, T., & Feng, Y. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101736 · Cited by 36
“Chronic retinal inflammation markers such as interleukin (IL)-6, IL-1b, IL-8, monocyte chemoattractant protein (MCP)-1, and tumor necrosis factor (TNF)-a, are detectable during the whole phase of DR as well as in cells treated with high glucose [60].”
BackgroundHydrogel Bioelectronics for Health Monitoring
Lyu, X., Hu, Y., Shi, S., Wang, S., Li, H., Wang, Y., & Zhou, K. (2023) · Biosensors · doi:10.3390/bios13080815 · Cited by 37
Joy, S. S., & Siddiqui, K. (2018) · Current Diabetes Reviews · doi:10.2174/1573399814666181017103844 · Cited by 33
Visual contrast sensitivity could be an early marker of diabetic retinopathy
Pramanik, S., Chowdhury, S., Ganguly, U., Banerjee, A., Bhattacharya, B., & Mondal, L. K. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05336 · Cited by 31
“DME could occur in both NPDR and PDR cases and represents the most common cause of vision loss among patients with DR (Rübsam et al., 2018).”
BackgroundZou, W., 张正威, Luo, S., Cheng, L., Huang, X., Ding, N., Yu, J., Pan, Y., & Wu, Z. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4833 · Cited by 33
“It has been demonstrated that dR can activate some signaling pathways and cause inflammatory response (7).”
BackgroundComparison of inflammatory cytokines levels in the aqueous humor with diabetic retinopathy
Zhang, H., Liang, L., Huang, R., Wu, P., & He, L. (2020) · International Ophthalmology · doi:10.1007/s10792-020-01463-9 · Cited by 30
Translatomic response of retinal Müller glia to acute and chronic stress
Chucair‐Elliott, A. J., Ocañas, S. R., Pham, K. D., Veldt, M. V. D., Cheyney, A., Stanford, D. R., Gurley, J. M., Elliott, M. H., & Freeman, W. M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105931 · Cited by 29
“Apart from their role in maintaining the normal physiology of the retina, MGC have been hypothesized to play an early role in the onset of inflammatory processes responsible for retinal damage at later stages of diabetic retinopathy (DR) (Rubsam et al., 2018), during glaucomatous degeneration (Choi et al.”
Diabetic Neuropathy of the Retina and Inflammation: Perspectives
Мухаррамовна, Б. Г., Oshitari, T., & Bikbov, M. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119166 · Cited by 34
Hirsch, G. E., & Heck, T. G. (2019) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1687522 · Cited by 36
“This association is well represented by the increased concentration of inflammatory cytokines and chemokines in serum and ocular (vitreous and aqueous humor) samples of diabetic patients (Rubsam et al. 2018).”
BackgroundEffect of dual PPAR-α/γ agonist saroglitazar on diabetic retinopathy and oxygen-induced retinopathy
Joharapurkar, A. A., PATEL, V. G., Kshirsagar, S. G., Patel, M. S., Savsani, H. H., & Jain, M. R. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174032 · Cited by 34
Lupo, G., Agafonova, A., Cosentino, A., Giurdanella, G., Mannino, G., Furno, D. L., Romano, I. R., Giuffrida, R., D’Angeli, F., & Anfuso, C. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24020913 · Cited by 29
“Elevated levels of inflammatory cytokines such as IL-1β, IL-6, IL-8, TNF-α, and MCP-1 have been found in ocular tissues from DR patients [9,10].”
BackgroundNiu, T., Shi, X., Liu, X., Wang, H., Liu, K., & Xu, Y. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00785-z · Cited by 30
Song, Y., Xia, T., Wang, X., & Feng, H. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1608220 · Cited by 30
Luo, R., Li, L., Hu, Y., & Xiao, F. (2020) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12302 · Cited by 32
“Inflammation is frequently observed in DR patients, which is highly associated with progression of DR.(7) Antiinflammation drugs could alleviate DR symptom,(19) indicating that inflammation played crucial roles in DR.”
BackgroundInfluentialSun, H., Zhao, H., Yan, Z., Liu, X., Yin, P., & Zhang, J. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10265 · Cited by 29
“Vascular dysfunction, including endothelial cell damage, pericyte death, retinal capillary basement membrane thickening and tight junction alterations has been a major focus of DR research; however, diabetic vascular dysfunction alone cannot explain the loss of retinal function (7).”
BackgroundInhibition of APE1/Ref-1 for Neovascular Eye Diseases: From Biology to Therapy
Hartman, G. D., Lambert-Cheatham, N. A., Kelley, M. R., & Corson, T. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910279 · Cited by 31
Circulating Biomarkers of Inflammation and Endothelial Activation in Diabetic Retinopathy
Storti, F., Pulley, J., Kuner, P., Abt, M., & Luhmann, U. F. O. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.12.8 · Cited by 33
Ghrelin Ameliorates Diabetic Retinal Injury: Potential Therapeutic Avenues for Diabetic Retinopathy
Bai, J., Yang, F., Wang, R., & Yan, Q. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8043299 · Cited by 29
“Inflammatory cytokines are highly expressed in the retinas of DR patients, promoting the occurrence and development of DR [7, 8].”
BackgroundThe role of the mTOR pathway in diabetic retinopathy
Casciano, F., Zauli, E., Rimondi, E., Mura, M., Previati, M., Busin, M., & Zauli, G. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.973856 · Cited by 32
Tang, L.-Y., Xiao, M., Cai, S., Mou, H., & Li, D. (2023) · Foods · doi:10.3390/foods12132600 · Cited by 34
Moon, C., Lee, A.-J., Jeon, H., Kim, E.-B., & Ha, K. (2023) · Theranostics · doi:10.7150/thno.81714 · Cited by 29
“endothelial cells; for instance, IL-1β and VEGF can upregulate each other and induce angiogenic responses [27, 32].”
Chen, H., Chen, E., Cao, T., Feng, F., Lin, M., Wang, X., & Xu, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1486251 · Cited by 32
Shi, Q., Wang, J., Cheng, Y.-H., Dong, X., Zhang, M., & Pei, C. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22489 · Cited by 30
Chai, G., Liu, S., Yang, H., Du, G., & Chen, X. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s264215 · Cited by 32
Immune Cell Landscape of Patients With Diabetic Macular Edema by Single-Cell RNA Analysis
Ma, P., Zhang, P., Chen, S., Shi, W., Ye, J., Chen, S., Ju, R., Liu, B., Zheng, Y., & Liu, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.754933 · Cited by 31
Wang, J.-H., Kumar, S., & Liu, G. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.14.22 · Cited by 29
“5 The mechanism behind these immune response-based manifestations in patients with retinal neovascularization remains unclear.”
Xu, F., Li, Z., Yang, X., Gao, Y., Li, Z., Li, G., Wang, S., Ning, X., & Li, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1036625 · Cited by 28
“00D), and other ocular conditions that may affect the choroidal and retinal capillaries; (6) Ocular media opacity; (7) Images of low quality (quality index < 6).”
BackgroundZhang, L., Yu, J., Ye, M., & Zhao, H. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0331-x · Cited by 28
The complement system and diabetic retinopathy
Jiang, F., Lei, C., Chen, Y., Zhou, N., & Zhang, M. (2024) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2024.02.004 · Cited by 42
Attenuating Diabetic Vascular and Neuronal Defects by Targeting P2rx7
Pavlou, S., Augustine, J., Cunning, R., Harkin, K., Stitt, A. W., Xu, H., & Chen, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092101 · Cited by 28
Rasoulinejad, S. A., Karkhah, A., Paniri, A., Saleki, K., Pirzadeh, M., & Nouri, H. R. (2020) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2020.1808986 · Cited by 30
Xu, Y., Zhang, Y., Liang, H., & Liu, X. (2021) · Aging · doi:10.18632/aging.202467 · Cited by 27
“Despite advances in improving the the retinal vascular alterations, DR still poses as a major challenge in clinical therapy [8].”
BackgroundFingolimod and Diabetic Retinopathy: A Drug Repurposing Study
Gesualdo, C., Baltă, C., Platania, C. B. M., Trotta, M. C., Herman, H., Gharbia, S., Roșu, M., Petrillo, F., Giunta, S., Corte, A. D., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.718902 · Cited by 27
“The increase of these inflammatory mediators has been proposed to contribute to early neurovascular retinal dysfunction (Vujosevic and Simó, 2017; Rübsam et al., 2018; Fu et al., 2020).”
BackgroundZhang, R., Huang, C., Chen, Y., Li, T., & Pang, L. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-1546 · Cited by 27
“The dysfunction of retinal glial cells, such as astrocytes, Müller glia, and microglia, may contribute to early retinal inflammatory processes in DR (16).”
Functional diabetic retinopathy: A new concept to improve management of diabetic retinal diseases
Rai, B. B., Maddess, T., & Nolan, C. J. (2024) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2024.11.010 · Cited by 34
D’Amico, A. G., Maugeri, G., Rasà, D. M., Federico, C., Saccone, S., Lazzara, F., Fidilio, A., Drago, F., Bucolo, C., & D’Agata, V. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27331 · Cited by 29
“inflammatory effect have been tested to inhibit the microvascular changes occurring downstream inflammation event (Rübsam et al., 2018).”
BackgroundAlfarhan, M., Liu, F., Shan, S., Pichavaram, P., Somanath, P. R., & Narayanan, S. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042133 · Cited by 28
“Inflammation plays an important role in developing ocular diseases such as DR [67], AMD [4], retinitis pigmentosa [6], and glaucoma [68].”
BackgroundZhu, H., Chen, Y., Gong, W.-K., Lai, J., Yao, B.-B., Zhao, Z., Lu, Q., Ye, K., Ji, L., & Xu, J. (2022) · Diabetes and Vascular Disease Research · doi:10.1177/14791641221122918 · Cited by 26
Silymarin reduces retinal microvascular damage in streptozotocin-induced diabetic rats
Karimi, R., Bakhshi, A., Dayati, P., Abazari, O., Shahidi, M., Savaee, M., Kafi, E., Rahmanian, M., & Naghib, S. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-20297-2 · Cited by 27
Elucidating glial responses to products of diabetes-associated systemic dyshomeostasis
Padovani-Claudio, D. A., Ramos, C. J., Capozzi, M. E., & Penn, J. S. (2023) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101151 · Cited by 30
Macrophage activation contributes to diabetic retinopathy
Zhang, Y., & Zhou, A. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-024-02437-5 · Cited by 28
“Under stress conditions such as increased blood glucose [8], retinal homeostasis is disrupted, triggering inflammatory reactions and immune cell responses [9].”
Zeiner, J., Loukovaara, S., Losenkova, K., Zuccarini, M., Korhonen, A., Lehti, K., Kauppinen, A., Kaarniranta, K., Müller, C. E., Jalkanen, S., et al. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-018-01734-0 · Cited by 26
Metadata
- Authors
- Rübsam, A., Parikh, S., & Fort, P.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Fort, Patrice
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-03-22
- Volume
- 19
- Issue
- 4
- Pages
- 942
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5979417
- OpenAlex
- W2793401320
- Cited by
- 750
- References
- 249
- Citations by year
- 2026: 46 · 2025: 91 · 2024: 107 · 2023: 118 · 2022: 127 · 2021: 107 · 2020: 83 · 2019: 59 · 2018: 11
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Eye Institute (R01-EY020895)
- Deutsche Forschungsgemeinschaft (RU 2020/2-1)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- diabetic retinopathy, inflammation, neuroglial interactions, retinal microvasculature, oxidative stress, advanced glycation end products, vascular endothelial growth factor, glial cells, neurons, diabetes complications
- MeSH terms
- Animals, Astrocytes, Diabetic Retinopathy, Humans, Inflammation, Neurodegenerative Diseases, Ependymoglial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.